Non-inferiority clinical trials: What they are and when they should be done

Area of Science:

• Clinical Trials Methodology
• Evidence-Based Medicine
• Pharmaceutical Research

Background:

• Randomized controlled trials (RCTs) are the standard for evaluating novel interventions.
• Superiority trial designs aim to prove a new intervention is better than existing ones.
• Alternative trial designs are needed when new interventions offer benefits beyond efficacy, such as improved safety.

Purpose of the Study:

• To discuss the utility and principles of non-inferiority (NI) trial designs.
• To highlight situations where NI designs are preferable to superiority designs.
• To illustrate the application of NI designs using examples from anticoagulation trials in atrial fibrillation.

Main Methods:

• Discussion of the principles underlying non-inferiority trial design.
• Explanation of sequential analysis for superiority testing post-NI demonstration.
• Case examples from published anticoagulation trials in atrial fibrillation.

Main Results:

• Non-inferiority designs provide a framework for evaluating interventions with added benefits (e.g., safety).
• Pre-specified sequential superiority analysis can follow a successful non-inferiority demonstration.
• The utility of NI designs is exemplified by their application in real-world clinical studies.

Conclusions:

• Non-inferiority trial designs offer a valuable alternative to superiority designs in specific clinical contexts.
• NI designs, when appropriately implemented, allow for a comprehensive evaluation of novel interventions.
• The use of NI designs can enhance the evidence base for treatments with multifaceted advantages.